Human tissue, such as blood and bone marrow, is the main starting material in cell-based research and clinical studies. Donors are the source of these tissues, and having access to donors facilitates ongoing innovative research. Equally important is the quality of the tissue. Tissue from donors comprises living cells, and given that each donor cellular makeup is unique, variability exists. Variable, low-quality tissue can create costly and time-consuming issues from the start of any research or clinical study.
StemExpress is the leading provider of high-quality IRB-consented human whole tissue (blood and bone marrow) and primary cells. Four nationwide Collection Centers increase an already extensive and well-established donor pool with donors of diverse demographics and backgrounds, providing quick and easy access to the right donor for any study. Each Collection Center collects tissue and ships it fresh, the day of collection or processes fresh tissue at a state-of-the-art on-site laboratory to various immune cells, stem cells, and primary cells.
StemExpress takes the necessary steps to assure regulatory compliance in the collection and production of high-quality human tissue and primary cells that meet or exceed the customer’s needs and requirements. Each collection and laboratory facility follows a quality system that encompasses Good Manufacturing Practice (GMP) guidelines, industry best practices, and strict quality assurance (QA) management systems to ensure the delivery of consistent, high-quality products.